These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [TBL] [Abstract][Full Text] [Related]
4. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
5. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [TBL] [Abstract][Full Text] [Related]
6. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [TBL] [Abstract][Full Text] [Related]
7. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD. van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931 [TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter genotype influences the physiological response to medication in ADHD. Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197 [TBL] [Abstract][Full Text] [Related]
10. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. Rovaris DL; Mota NR; da Silva BS; Girardi P; Victor MM; Grevet EH; Bau CH; Contini V Pharmacogenomics; 2014 Jul; 15(10):1365-81. PubMed ID: 25155937 [TBL] [Abstract][Full Text] [Related]
11. The genetics of attention-deficit/hyperactivity disorder. Coghill D; Banaschewski T Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843 [TBL] [Abstract][Full Text] [Related]
12. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143 [TBL] [Abstract][Full Text] [Related]
13. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications. Levy F Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676 [TBL] [Abstract][Full Text] [Related]
14. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Steele M; Jensen PS; Quinn DM Clin Ther; 2006 Nov; 28(11):1892-908. PubMed ID: 17213010 [TBL] [Abstract][Full Text] [Related]
15. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update. Prince J J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676 [TBL] [Abstract][Full Text] [Related]
16. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920 [TBL] [Abstract][Full Text] [Related]
17. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder. Cheon KA; Jun JY; Cho DY Int Clin Psychopharmacol; 2008 Sep; 23(5):291-8. PubMed ID: 18703939 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children. Kopecková M; Paclt I; Goetz P Neuro Endocrinol Lett; 2006 Dec; 27(6):748-54. PubMed ID: 17187001 [TBL] [Abstract][Full Text] [Related]
19. Review: Genetics of attention deficit/hyperactivity disorder. Wallis D; Russell HF; Muenke M J Pediatr Psychol; 2008; 33(10):1085-99. PubMed ID: 18522996 [TBL] [Abstract][Full Text] [Related]
20. Biochemical markers and genetic research of ADHD. Paclt I; Koudelová J; Krepelová A; Uhlíková P; Gazdíková M; Bauer P Neuro Endocrinol Lett; 2005 Aug; 26(4):423-30. PubMed ID: 16135997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]